Nanodiamond-DGEA peptide conjugates for enhanced delivery of doxorubicin to prostate cancer

The field of nanomedicine has emerged as an approach to enhance the specificity and efficacy of cancer treatments as stand-alone therapies and in combination with standard chemotherapeutic treatment regimens. The current standard of care for metastatic cancer, doxorubicin (DOX), is presented with ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Salaam, Amanee D, Hwang, Patrick, McIntosh, Roberus, Green, Hadiyah N, Jun, Ho-Wook, Dean, Derrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Beilstein-Institut 2014
Materias:
Full Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142852/
https://www.ncbi.nlm.nih.gov/pubmed/25161829
http://dx.doi.org/10.3762/bjnano.5.107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142852/
https://www.ncbi.nlm.nih.gov/pubmed/25161829
http://dx.doi.org/10.3762/bjnano.5.107

Ejemplares similares